Crystallographic Insight Into the Mechanism of Drug-Induced Topoisomerase I DNA Damage

[1]  Lance Stewart,et al.  The mechanism of topoisomerase I poisoning by a camptothecin analog , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Verweij,et al.  Modulation of camptothecin analogs in the treatment of cancer: a review , 2001, Anti-cancer drugs.

[3]  J. Champoux.  Structure‐Based Analysis of the Effects of Camptothecin on the Activities of Human Topoisomerase I , 2000, Annals of the New York Academy of Sciences.

[4]  M. Manfait,et al.  Kinetics of in Vitro Hydrolysis of Homocamptothecins As Measured by Fluorescence , 2000, Annals of the New York Academy of Sciences.

[5]  S. Shuman,et al.  Catalytic mechanism of DNA topoisomerase IB. , 2000, Molecular cell.

[6]  Y. Pommier,et al.  Substitutions of Asn-726 in the Active Site of Yeast DNA Topoisomerase I Define Novel Mechanisms of Stabilizing the Covalent Enzyme-DNA Intermediate* , 2000, The Journal of Biological Chemistry.

[7]  M. Bjornsti,et al.  Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. , 1999, Molecular pharmacology.

[8]  J. Champoux,et al.  A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation Assay* , 1999, The Journal of Biological Chemistry.

[9]  R. Kiss,et al.  Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties. , 1999, Cancer research.

[10]  S. Hecht,et al.  Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex. , 1999, Biochemistry.

[11]  Y. Pommier,et al.  Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNA. , 1998, Biochemistry.

[12]  J. Champoux,et al.  Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. , 1998, Science.

[13]  W G Hol,et al.  A model for the mechanism of human topoisomerase I. , 1998, Science.

[14]  L. Liu,et al.  Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis. , 1997, Biochemical pharmacology.

[15]  G. Ireton,et al.  Biochemical and Biophysical Analyses of Recombinant Forms of Human Topoisomerase I (*) , 1996, The Journal of Biological Chemistry.

[16]  H. Nash,et al.  A novel suicide substrate for DNA topoisomerases and site-specific recombinases. , 1995, Nucleic acids research.

[17]  A. Mildvan,et al.  Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions. , 1994, Biochemistry.

[18]  Eric Patterson,et al.  Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites , 1991, Nucleic Acids Res..

[19]  L. Liu,et al.  DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. , 1989, Science.

[20]  J. Wang,et al.  Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. , 1989, Cancer research.

[21]  L. Liu,et al.  DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. , 1989, Cancer research.

[22]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[23]  K. Kohn,et al.  Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity. , 1989, Cancer research.

[24]  R. Hertzberg,et al.  Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. , 1989, Journal of medicinal chemistry.

[25]  J. Wang,et al.  DNA topoisomerase-targeting antitumor drugs can be studied in yeast. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[27]  Wolfram Saenger,et al.  Principles of Nucleic Acid Structure , 1983 .

[28]  A. McPhail,et al.  Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2 , 1966 .

[29]  J. Champoux.  DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.

[30]  M. Bjornsti,et al.  Drug-induced stabilization of covalent DNA topoisomerase I-DNA intermediates. DNA cleavage assays. , 2001, Methods in molecular biology.

[31]  L. Liu,et al.  Tumor cell death induced by topoisomerase-targeting drugs. , 2001, Annual review of pharmacology and toxicology.

[32]  L. Shen.  DNA-unwinding test using eukaryotic DNA topoisomerase I. , 2001, Methods in molecular biology.

[33]  Y. Pommier,et al.  Topoisomerase I-mediated DNA damage. , 2001, Advances in cancer research.

[34]  L. Liu,et al.  DNA topoisomerases: essential enzymes and lethal targets. , 1994, Annual review of pharmacology and toxicology.